Edap TMS SA (EDAP)
2.47
-0.02
(-0.80%)
USD |
NASDAQ |
Nov 22, 16:00
2.47
0.00 (0.00%)
After-Hours: 20:00
Edap TMS Total Return Price: 2.47 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 2.47 |
November 21, 2024 | 2.49 |
November 20, 2024 | 2.45 |
November 19, 2024 | 2.39 |
November 18, 2024 | 2.36 |
November 15, 2024 | 2.45 |
November 14, 2024 | 2.52 |
November 13, 2024 | 2.63 |
November 12, 2024 | 2.64 |
November 11, 2024 | 2.54 |
November 08, 2024 | 2.565 |
November 07, 2024 | 2.73 |
November 06, 2024 | 2.835 |
November 05, 2024 | 2.76 |
November 04, 2024 | 2.69 |
November 01, 2024 | 2.86 |
October 31, 2024 | 2.90 |
October 30, 2024 | 2.99 |
October 29, 2024 | 3.00 |
October 28, 2024 | 2.90 |
October 25, 2024 | 2.73 |
October 24, 2024 | 2.52 |
October 23, 2024 | 2.41 |
October 22, 2024 | 2.615 |
October 21, 2024 | 2.76 |
Date | Value |
---|---|
October 18, 2024 | 2.71 |
October 17, 2024 | 2.65 |
October 16, 2024 | 2.73 |
October 15, 2024 | 2.75 |
October 14, 2024 | 2.70 |
October 11, 2024 | 2.62 |
October 10, 2024 | 2.62 |
October 09, 2024 | 2.62 |
October 08, 2024 | 2.68 |
October 07, 2024 | 2.69 |
October 04, 2024 | 2.64 |
October 03, 2024 | 2.58 |
October 02, 2024 | 2.63 |
October 01, 2024 | 2.71 |
September 30, 2024 | 2.55 |
September 27, 2024 | 2.81 |
September 26, 2024 | 2.87 |
September 25, 2024 | 2.92 |
September 24, 2024 | 2.99 |
September 23, 2024 | 2.98 |
September 20, 2024 | 3.05 |
September 19, 2024 | 3.05 |
September 18, 2024 | 3.08 |
September 17, 2024 | 3.15 |
September 16, 2024 | 3.24 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
1.716
Minimum
Mar 18 2020
12.48
Maximum
Mar 03 2023
6.404
Average
6.36
Median
Jul 09 2021
Total Return Price Benchmarks
DBV Technologies SA | 0.469 |
Cellectis SA | 1.87 |
Genfit SA | 4.20 |
Adaptimmune Therapeutics PLC | 0.6616 |
Akari Therapeutics PLC | 1.30 |